Delivery of diagnostic agents in computed tomography.

[1]  E. D. Osborne,et al.  ROENTGENOGRAPHY OF URINARY TRACT DURING EXCRETION OF SODIUM IODID , 1923 .

[2]  V. Taenzer,et al.  Pharmakokinetik und Plasmaeiweißbindung von Iotroxinsäure , 1977 .

[3]  M. Violante,et al.  Biodistribution of a particulate hepatolienographic CT contrast agent: a study of iodipamide ethyl ester in the rat. , 1980 .

[4]  C. Higgins,et al.  Perfluoroctylbromide: a reticuloendothelial-specific and tumor-imaging agent for computed tomography. , 1982, Radiology.

[5]  M. Amiel.  Contrast Media in Radiology , 1982, Springer Berlin Heidelberg.

[6]  R. Souchon,et al.  Water-soluble Contrast Agents for Computed Tomography of the Liver: Experimental Studies in Dog , 1982 .

[7]  P. J. Ryan,et al.  The preparation and characterization of liposomes containing X-ray contrast agents. , 1983, Biochimica et biophysica acta.

[8]  D. Miller,et al.  Experimental comparison of EOE-13 and perfluoroctylbromide for the CT detection of hepatic metastases. , 1984, Investigative radiology.

[9]  W. Mützel,et al.  Pharmakokinetik des nichtionischen Röntgenkontrastmittels Iohexol , 1984 .

[10]  J. Barnhart.  Hepatic Disposition and Elimination of Biliary Contrast Media , 1984 .

[11]  Jendrasiak Gl,et al.  Liposomes as carriers of iodolipid radiocontrast agents for CT scanning of the liver. , 1985 .

[12]  G. Whitehouse,et al.  Delineation of the spleen by a combination of proliposomes with water-soluble contrast media: an experimental study using computed tomography. , 1987, The British journal of radiology.

[13]  S. Seltzer,et al.  The production and evaluation of contrast-carrying liposomes made with an automatic high-pressure system. , 1987, Investigative radiology.

[14]  S. Seltzer,et al.  Characterization of liposomes containing iodine-125-labeled radiographic contrast agents. , 1987, Investigative radiology.

[15]  M. Violante,et al.  Uptake and dissolution of particulate iodipamide ethyl ester in the spleen. A morphologic study. , 1987, Investigative radiology.

[16]  S E Seltzer,et al.  Evaluation of the dehydration-rehydration method for production of contrast-carrying liposomes. , 1988, Investigative radiology.

[17]  V. Sturm,et al.  In vitro release and depot effect after intratumoral application of metrizamide-containing liposomes. , 1989, Arzneimittel-Forschung.

[18]  R. McCuskey,et al.  Experimental Investigation of a New Iodinated Lipid Emulsion for Computed Tomography of the Liver , 1989, Acta radiologica.

[19]  A. Henze,et al.  Radio-opaque liposomes for the improved visualisation of focal liver disease by computerized tomography. , 1989, Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society.

[20]  P. Hochbergs,et al.  Clinical Trials with a New Iodinated Lipid Emulsion for Computed Tomography of the Liver , 1989, Acta radiologica.

[21]  B. Coley,et al.  AUR Memorial Award 1990. The physiologic basis of the radiodense renal medulla after the administration of blood pool contrast agent PFOB. , 1990, Investigative radiology.

[22]  S. Seltzer,et al.  Production and characterization of improved liposomes containing radiographic contrast media. , 1990, Investigative radiology.

[23]  M. Schaefer,et al.  Iodinated polymers. Pharmacokinetics of blood-pool imaging products. , 1990, Investigative radiology.

[24]  S. Wagner,et al.  Preclinical Characterization of Iopromide‐Carrying Liposomes , 1991, Investigative radiology.

[25]  B. Bonnemain,et al.  Blood‐Pool X‐Ray Contrast Agents: Evaluation of a New Iodinated Polymer , 1991, Investigative radiology.

[26]  C. Corot,et al.  Iodinated Polymer as Blood‐Pool Contrast Agent: Computed Tomography Evaluation in Rabbits , 1991, Investigative radiology.

[27]  R. Mattrey.  Blood‐Pool Contrast Media Are the Ideal Agents for Computed Tomography , 1991, Investigative radiology.

[28]  H. Weinmann,et al.  Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. , 1992, Radiology.

[29]  S. Olliff,et al.  Persistence of lipiodol for 13 months in metastatic deposits in the liver on computed tomography. , 1992, Clinical radiology.

[30]  R. Felix,et al.  Kontrastgebung von Jod, Gadolinium und Ytterbium in der CT , 1993 .

[31]  I. Morris,et al.  Hepatic kinetics and magnetic resonance imaging of gadolinium ethoxybenzyl diethylenetriaminepentacetic acid (Gd-EOB-DTPA) in dogs. , 1993, Australasian radiology.

[32]  S. Wagner,et al.  Preparation and Evaluation of Lyophilized Iopromide‐Carrying Liposomes for Liver Tumor Detection , 1993, Investigative radiology.

[33]  D. Carney,et al.  Perfluorooctylbromide as a contrast agent for CT and sonography: preliminary clinical results. , 1993, AJR. American journal of roentgenology.

[34]  G. Schuhmann-Giampieri,et al.  Characterization of Iopromide Liposomes , 1993, Investigative radiology.

[35]  J. P. Bronson,et al.  Liver enhancement techniques in computed tomography. A comparison of intravenous bolus, computed tomographic portography, and iodipamide ethyl ester particle injections in a canine model. , 1994, Investigative radiology.

[36]  G. Schuhmann-Giampieri,et al.  Characterization of Iopromide-Carrying Liposomes , 1994 .

[37]  H. Fujii,et al.  Prediction of Recurrence after HCC Resection , 1994, Acta radiologica.

[38]  Chun Xing Li,et al.  Preparation, Characterization, and Evaluation of Ioxilan Carbonate Particles for Computed Tomography Contrast Enhancement of Liver , 1994, Investigative radiology.

[39]  F. Bakir,et al.  Blood pool radiopaque polymers. Design considerations. , 1994, Investigative radiology.

[40]  C. Tilcock,et al.  PEG-coated lipid vesicles with encapsulated technetium-99m as blood pool agents for nuclear medicine. , 1994, Nuclear medicine and biology.

[41]  U. Schmiedl,et al.  Liver contrast enhancement in primates using iopromide liposomes. , 1995, Academic radiology.

[42]  W. Krause,et al.  Liposomes in Diagnostic Imaging – Comparison of Modalities – In-vivo Visualization of Liposomes - , 1995 .

[43]  F. Terrier,et al.  Enhancement of computed tomography liver contrast using iomeprol-containing liposomes and detection of small liver tumors in rats. , 1995, Academic radiology.

[44]  A. Sachse,et al.  Lipid Dependent Cardio- Haemodynamic Tolerability of Liposomes in Rats , 1995 .

[45]  S. Seltzer,et al.  Contrast material-carrying liposomes: biodistribution, clearance, and imaging characteristics. , 1995, Radiology.

[46]  H. Wallin,et al.  Lung carcinoma and malignant mesothelioma in patients exposed to thorotrast: Incidence, histology and p53 status , 1995, International journal of cancer.

[47]  J. Schramm,et al.  Presence and removal of arteriovenous malformation: Impact of regional cerebral blood flow, as assessed with Xenon/CT , 1996, Acta neurologica Scandinavica. Supplementum.

[48]  W. Krause.  Application of pharmacokinetics to computed tomography: injection rates and schemes: mono-, bi-, or multiphasic? , 1996, Investigative radiology.

[49]  R. Counsell,et al.  Physicochemical characterization of a synthetic lipid emulsion for hepatocyte-selective delivery of lipophilic compounds: application to polyiodinated triglycerides as contrast agents for computed tomography. , 1996, Journal of pharmaceutical sciences.

[50]  C. Bartolozzi,et al.  Small Hepatocellular Carcinoma , 1996, Acta radiologica.

[51]  U. Schmiedl,et al.  Iopromide-carrying liposomes as a contrast agent for the liver. , 1996, Academic radiology.

[52]  Chun Xing Li,et al.  Development of biodegradable ioxilan carbonate particles for contrast enhancement of the liver in computed tomography scanning: toxicity assessment. , 1996, Academic radiology.

[53]  F. Lee,et al.  Preclinical evaluation of an iodinated particulate contrast agent for use during angiography: work in progress. , 1996, Journal of vascular and interventional radiology : JVIR.

[54]  W Krause,et al.  Ytterbium- and dysprosium-EOB-DTPA. A new prototype of liver-specific contrast agents for computed tomography. , 1996, Investigative radiology.

[55]  A. Sachse,et al.  Biodistribution and Ct-Imaging Characteristics of Iopromide-Carrying Liposomes in Rats , 1996 .

[56]  Chun Xing Li,et al.  Biodistribution of cyclic carbonate of ioxilan: a radiopaque particulate macrophage imaging agent. , 1996, Academic radiology.

[57]  J. Tacke,et al.  Computed tomography of experimental liver abscesses using a new liposomal contrast agent. , 1996, Investigative radiology.

[58]  P. Leander.  A New Liposomal Contrast Medium for CT of the Liver , 1996 .

[59]  A. Kopp,et al.  Liver-specific contrast media: a magic bullet or a weapon for dedicated targets? , 1997, Radiology.

[60]  A. Sundin,et al.  CT of experimental hepatoma using the hepatocyte-specific lipid emulsion fp 736-03 , 1997, Acta radiologica.

[61]  C. Bartolozzi,et al.  Intrahepatic metastatic nodules of hepatocellular carcinoma detected at Lipiodol-CT: imaging-pathologic correlation , 1997, Abdominal Imaging.

[62]  A Bergman,et al.  Hepatocyte-specific contrast media for CT. An experimental investigation. , 1997, Acta radiologica. Supplementum.

[63]  R. Srinivasan,et al.  Thorotrast and the liver--revisited. , 1997, Journal of toxicology. Clinical toxicology.

[64]  M. Brandl,et al.  Biodistribution and computed tomography blood-pool imaging properties of polyethylene glycol-coated iopromide-carrying liposomes. , 1997, Investigative radiology.

[65]  A. Sundin,et al.  CT with the hepatocyte-specific contrast medium fp 736-04 in an experimental model of liver steatosis , 1997, Acta radiologica.

[66]  P. Deol,et al.  Lung specific stealth liposomes: stability, biodistribution and toxicity of liposomal antitubercular drugs in mice. , 1997, Biochimica et biophysica acta.

[67]  K J Wolf,et al.  Detection of focal liver lesions: CT of the hepatobiliary system with gadoxetic acid disodium, or Gd-EOB-DTPA. , 1997, Radiology.

[68]  S. Schmitz,et al.  A prototype liver-specific contrast medium for CT: preclinical evaluation of gadoxetic acid disodium, or Gd-EOB-DTPA. , 1997, Radiology.

[69]  T. Allen,et al.  Liposomes , 2012, Drugs.

[70]  J. Kuhlman,et al.  CT depiction of experimental liver tumors: contrast enhancement with hepatocyte-selective iodinated triglyceride versus conventional techniques. , 1997, Radiology.

[71]  W. Krause.  In vitro and animal experiments in contrast media testing. , 1998, Investigative radiology.